Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

Coronavirus disease 2019 (COVID-19) is a new pandemic characterized by quick spreading and illness of the respiratory system. To date, there is no specific therapy for Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Flavonoids, especially rutin, have attracted considerable interest as...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Mahmoud A.A., Mohamed, Eslam A.R., Abdelrahman, Alaa H.M., Allemailem, Khaled S., Moustafa, Mahmoud F., Shawky, Ahmed M., Mahzari, Ali, Hakami, Abdulrahim Refdan, Abdeljawaad, Khlood A.A., Atia, Mohamed A.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980232/
https://www.ncbi.nlm.nih.gov/pubmed/33798836
http://dx.doi.org/10.1016/j.jmgm.2021.107904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980232/
https://www.ncbi.nlm.nih.gov/pubmed/33798836
http://dx.doi.org/10.1016/j.jmgm.2021.107904

Ejemplares similares